$ARCT 8-K SEC Filings

Filed On	Filing
23 Sep 2026	8-K: Regulation FD Disclosure Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform
25 Aug 2026	8-K: Regulation FD Disclosure
06 Aug 2026	8-K: Results of Operations and Financial Condition
02 Jul 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
05 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
03 Mar 2026	8-K: Results of Operations and Financial Condition
15 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
10 Nov 2025	8-K: Results of Operations and Financial Condition
22 Oct 2025	8-K: Regulation FD Disclosure; Other Events
26 Sep 2025	8-K: Regulation FD Disclosure
29 Aug 2025	8-K: Regulation FD Disclosure
11 Aug 2025	8-K: Results of Operations and Financial Condition
30 Jun 2025	8-K: Regulation FD Disclosure
06 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
12 May 2025	8-K: Results of Operations and Financial Condition
06 Mar 2025	8-K: Results of Operations and Financial Condition
07 Nov 2024	8-K: Results of Operations and Financial Condition
13 Aug 2024	8-K: Regulation FD Disclosure
05 Aug 2024	8-K: Results of Operations and Financial Condition

Comments